Akamis Bio vs TME Pharma
Akamis Bio
Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer
50 employees · est. 2010 · Abingdon, United Kingdom
TME Pharma
Developing novel therapies for treatment of the most aggressive cancers by acting on the tumor microenvironment (TME)
12 employees · est. 1998 · Berlin, Germany
TME Pharma is the older company (2010 vs 1998).
Side-by-Side Comparison
| Metric | Akamis Bio | TME Pharma |
|---|---|---|
| Founded | ||
| Founded | 2010 | 1998 older |
| Headquarters | ||
| Headquarters | Abingdon, United Kingdom | Berlin, Germany |
| Employees | ||
| Employees | 50 | 12 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Convertible Note | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $102.70M | $138.73M |
| Funding Rounds | ||
| Funding Rounds | 9 | 13 |
| Services | ||
| Services | Not tracked yet | development of novel cancer therapies, conducting and managing clinical trials, scientific research and development, collaborative therapeutic solutions |
| Target Customers | ||
| Target Customers | Not tracked yet | oncologists, medical researchers, pharmaceutical companies, healthcare providers, cancer patients |
| Taxonomy | ||
| Taxonomy | Not tracked yet | Tumor MicroenvironmentCancer TherapiesGlioblastomaNOX-A12Spiegelmer PlatformImmune System Modulation +9 |
| Website | ||
| Website | akamisbio.com | tmepharma.com |
About Akamis Bio
Akamis Bio is a biotechnology company founded in 2010. Specializing in the Biotechnology and Health Care industries, it has received a significant $30.00M investment through a Convertible Note investment in 05 January 2023. This investment comes from reputable investors such as Arch Venture Partners...
About TME Pharma
TME Pharma is a clinical-stage biotechnology company headquartered in Germany, specializing in developing novel therapies targeting the tumor microenvironment (TME) which is crucial in treating aggressive forms of cancer. With a mission to enhance treatment outcomes, the company’s platform aims at b...
Also comparing in this category
Comparing more than these two?
Get Akamis Bio, TME Pharma and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Akamis Bio compare?
A PDF of Akamis Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Akamis Bio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Akamis Bio on 12 Sep 2024, and TME Pharma on 14 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
